KU Hematology & Medical Oncology Review 2019

 

KU Hematology & Medical Oncology Review 2019
Avatar

KU ASCO 2019 Update on Surgical Treatment of Melanoma & Adjuvant Ipilimumab in High-Risk Melanoma

By KU Hematology & Medical Oncology Review 2019 FEATURING Gary Doolittle
By KU Hematology & Medical Oncology Review 2019 FEATURING Gary Doolittle
68 views
August 22, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss
Skin
12:46

KU ASCO 2019 Update on Surgical Treatment of Melanoma & Adjuvant Ipi…

KU Hematology & Medical Oncology Review 2019

G. Doolittle

68 views
07:50

KU ASCO 2019 Updates on Trial Discussing Nivolumab + Ipilimumab in M…

KU Hematology & Medical Oncology Review 2019

G. Doolittle

258 views
08:44

KU ASCO 2019 Long-Term Survival of Dabrafenib Plus Trametinib in Met…

KU Hematology & Medical Oncology Review 2019

G. Doolittle

240 views